期刊论文详细信息
JOURNAL OF HEART AND LUNG TRANSPLANTATION 卷:37
A roadmap for evaluating the use and value of durable ventricular assist device therapy
Article
Ward, Sarah T.1  Liang, Qixing1  Pagani, Francis D.1  Zhang, Min1  Kormos, Robert L.2  Aaronson, Keith D.1  Althouse, Andrew D.2  Nallamothu, Brahmajee K.3  Likosky, Donald S.1 
[1] Univ Michigan, Dept Cardiac Surg, Ann Arbor, MI 48109 USA
[2] Univ Pittsburgh, Med Ctr, Heart & Vasc Inst, Pittsburgh, PA USA
[3] Univ Michigan, Div Cardiovasc Med, Ann Arbor, MI 48109 USA
关键词: heart failure;    left ventricular assist device;    durable LVAD therapy;    bridge to transplant;    factors;   
DOI  :  10.1016/j.healun.2017.06.008
来源: Elsevier
PDF
【 摘 要 】

Heart failure is a disease characterized by profound human suffering with limitations in survival despite treatment with guideline-directed medical therapies. Patients with heart failure frequently progress to advanced stages and often require cardiac transplantation or implantation of left ventricular assist devices (LVADs) to extend survival and improve quality of life. As the number of suitable heart donors, number of experienced medical centers and patient comorbidities place restrictions on the feasibility of cardiac transplantation, implantation of LVADs has emerged as a more frequently applied treatment as either a bridge to transplantation or as permanent therapy. Considerable data have documented improvements in survival, functional status and quality of life offered by LVADs, however, few studies have focused on identifying: (1) determinants of LVAD use across medical centers, (2) the relationship between the determinants of LVAD use and value (defined as quality divided by cost), and (3) how determinants of LVAD use are influenced or impacted by vulnerable populations. We propose a conceptual model that integrates the main determinants of LVAD utilization, which include technology, insurance coverage, market-, provider- and patient-level factors. We propose this paradigm as a necessary prerequisite for understanding LVAD usage and value. This conceptual framework provides a broader view for future studies, which are needed to inform emerging healthcare policies that influence dissemination of this expensive but life-prolonging medical therapy.

【 授权许可】

Free   

【 预 览 】
附件列表
Files Size Format View
10_1016_j_healun_2017_06_008.pdf 883KB PDF download
  文献评价指标  
  下载次数:2次 浏览次数:0次